# Black Tea Blood Pressure Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/black-tea-blood-pressure-meta-analysis-evidence-review
Category: evidence-review
Summary: Black Tea Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-08-15
Reviewed by: Migaku Evidence Review
# Black Tea Blood Pressure Meta-analysis: What the Evidence Says

## Quick Answer

Black Tea Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The Acute Effects of Caffeine on OCT and OCTA Parameters: A Systematic Review and Meta-Analysis | systematic review | 1 | 2026-04-11 | 10.2147/OPTH.S568498 |
| The association between polyphenol consumption and stroke risk factors in Saudi Arabia | research article | 4 | 2026-01-06 | 10.3389/fnut.2025.1696220 |

## What The Sources Report

- For instance, nicotine has been reported to exert ischemic effects on retinochoroidal and vascular structures.Conversely, specific agents have been associated with increased choroidal thickness, including intraocular pressure-lowering medications, topical atropine, and the systemic administration of &#946;-blockers and ethanol. [Veiga Davi Mar&#231;ola (2026); evidence level 1]
- Therefore, a systematic evaluation of the available evidence is warranted to quantify the acute effects of caffeine and caffeinated beverages on structural and microvascular parameters assessed by OCT and OCTA. [Veiga Davi Mar&#231;ola (2026); evidence level 1]
- According to Boehme and Esenwa, treatable risk factors include alcohol use, atrial cardiopathy, diabetes mellitus, hypertension, dyslipidemia, obesity, infection and inflammation, substance abuse, and smoking. [Alsharif Sarah N. (2026); evidence level 4]
- Age, sex, race and ethnicity, and heredity are examples of untreatable risk factors. [Alsharif Sarah N. (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For black tea blood pressure meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Veiga Davi Mar&#231;ola (2026). The Acute Effects of Caffeine on OCT and OCTA Parameters: A Systematic Review and Meta-Analysis. DOI: 10.2147/OPTH.S568498. PMCID: PMC13084639. PMID: 42004639. License: https://creativecommons.org/licenses/by-nc/4.0/ https://www.dovepress.com/terms.php http://creativecommons.org/licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13084639/
- Alsharif Sarah N. (2026). The association between polyphenol consumption and stroke risk factors in Saudi Arabia. DOI: 10.3389/fnut.2025.1696220. PMCID: PMC12815862. PMID: 41567329. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12815862/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.